title: Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?
authors: Department of Haematology, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK.
authors: Gillian G
authors: GG
authors: Johnson
authors: Daniel F
authors: DF
authors: Carr
authors: Munir
authors: M
authors: Pirmohamed
authors: Andrew R
authors: AR
authors: Pettitt
mesh_terms: D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000235:genetics*; D010597:Pharmacogenetics
chemical_list: D003520:Cyclophosphamide
keywords: adverse drug reactions; bendamustine; chronic lymphocytic leukemia; cyclophosphamide; fludarabine; personalized medicine; pharmacogenomics